Sean E. Bland, JD, provides insight for when a health plan or issuer may use reasonable medical-management techniques, in accordance with USPSTF guidelines for HIV PrEP, and Ryan Bitton, PharmD, MBA, ...

Ryan Bitton, PharmD, MBA, and Frank J. Palella, MD, discuss facts about the implementation of USPSTF guidelines for HIV PrEP therapy. Ryan Haumschild, PharmD, MS, MBA: Thank you. It’s such a complex ...

We are writing in response to “The Task Force’s Latest PrEP Recommendation For HIV Is Just More Of The Same” by Richard Hughes IV, published in Forefront on November 1, 2023. We share the author’s ...

In their recent response to my earlier article, Amy Killelea and Jeremiah Johnson take a position that overlooks patient access concerns and undermines innovation toward newer and better forms of PrEP ...

Please provide your email address to receive an email when new articles are posted on . The CDC released a draft of revised clinical practice guidelines for HIV PrEP and took feedback from clinicians ...

Starting today, the Centers for Disease Control and Prevention (CDC) recommends all clinicians talk to their sexually active adolescent and adult patients about HIV preexposure prophylaxis (PrEP) at ...

The US Centers for Disease Control and Prevention is encouraging doctors to talk to all sexually active people about drugs that can help prevent HIV and to prescribe these drugs – known as ...

World Health Organisation (WHO) has released new guidelines for the use of long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. Director of WHO’s Global HIV, Hepatitis and ...

The guidelines emphasize that PrEP use in the HIV negative male is essential in the prevention of the spread of the virus to these individuals and the fetus. The CDC document also highlights an ...